Upon completion of this program participants should be able to:
1. Evaluate the strength and weakness of each major imaging modality for Molecular Imaging, and
identify novel hybrid imaging techniques in the field.
2. Recognize common principles behind Molecular Imaging probes for each individual imaging
modality, as well as the potential of multi-modality probes.
3. Recognize the potential of Molecular Imaging for depicting and following specific molecular and
cellular processes in vivo.
4. Evaluate the potential, strengths and weaknesses of Molecular Imaging for specific organs and
5. Describe the principles of Molecular Imaging techniques for guiding and assessing therapeutic
interventions, including drug development and therapy.
6. Recognize the potential, strengths and weaknesses of specific Molecular Imaging for preclinical,
clinical, and translational research.
CME Joint Sponsorship Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of
the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of
the Society of Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) and the World Molecular Imaging
Society. The SNMMI is accredited by the ACCME to provide continuing medical education for physicians.
The Society of Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) designates this live activity for
AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of
their participation in the activity.
Disclosure of Financial Interests and Relationships
To ensure balance, independence, objectivity and scientific rigor in all CME programs it is the policy of
the SNMMI and the World Molecular Imaging Congress (WMIC) 2021 that any speaker who makes a
presentation at a program designated for AMA Physician’s Recognition Award (PRA) Category 1 credit
must disclose any real or apparent financial interest or other relationship (i.e., grants, research support,
consultant, honoraria) that the speaker may have with the manufacturers, distributors or providers of
any commercial products or services that may be discussed in the presentation. If a speaker does not
submit a declaration statement form he or she cannot speak on the program.
The SNMMI does not imply that such financial interests or relationships are inherently improper or that
such interests or relationships would prevent the speaker from making an objective presentation.
However, it is imperative that such financial interests or relationships be identified by the speaker so
they may be resolved in advance, and so that participants may have these facts fully disclosed prior to
the presentation, and may form their own judgments about the presentation.
Unlabeled Uses of Products
When an unlabeled use of a commercial product or an investigational use not yet approved for any
purpose, is discussed during an educational activity, the presenter is required to disclose that the
product is not labeled for the use under discussion or that the product is still investigational.
Sessions that have been approved for CME credits are noted by each session.